Page 2,877«..1020..2,8762,8772,8782,879..2,8902,900..»

Category Archives: Transhuman News

Fronteres del Coneixement: The Human Genome Diversity Group, Institut de Biologia Evolutiva – Video

Posted: December 10, 2014 at 2:43 pm


Fronteres del Coneixement: The Human Genome Diversity Group, Institut de Biologia Evolutiva
Fronteres del Coneixement, s una srie de vdeos de divulgaci cientfica, en la que es mostra el dia a dia de cinc grups de recerca de cinc diferents lnies d #39;investigaci a l #39;Institut...

By: IBE LCATM

Read more here:
Fronteres del Coneixement: The Human Genome Diversity Group, Institut de Biologia Evolutiva - Video

Posted in Genome | Comments Off on Fronteres del Coneixement: The Human Genome Diversity Group, Institut de Biologia Evolutiva – Video

December 8th – Susie Maidment – Cosmic Genome Science Advent Calendar – Video

Posted: at 2:43 pm


December 8th - Susie Maidment - Cosmic Genome Science Advent Calendar
A look back into the archive with a section of Dr Susie Maidment #39;s episode of Science School where she brought in her stegosaurus tail spike to show us. Every day a new free science clip...

By: The Incomplete Map of the Cosmic Genome

See the original post here:
December 8th - Susie Maidment - Cosmic Genome Science Advent Calendar - Video

Posted in Genome | Comments Off on December 8th – Susie Maidment – Cosmic Genome Science Advent Calendar – Video

Tsunamaru – Daidai Genome [Insane] + DT – Video

Posted: at 2:43 pm


Tsunamaru - Daidai Genome [Insane] + DT
AR 9.6 My blog : http://ehgur5146.blog.me/

By: dh jeong

Continue reading here:
Tsunamaru - Daidai Genome [Insane] + DT - Video

Posted in Genome | Comments Off on Tsunamaru – Daidai Genome [Insane] + DT – Video

Using genome sequencing to track MRSA in under-resourced hospitals

Posted: at 2:43 pm

PUBLIC RELEASE DATE:

9-Dec-2014

Contact: Sarah Collins sarah.collins@admin.cam.ac.uk 44-012-237-65542 University of Cambridge @Cambridge_Uni

Researchers from the University of Cambridge have used genome sequencing to monitor how the spread of methicillin-resistant Staphylococcus aureus (MRSA) occurs in under-resourced hospitals. By pinpointing how and when MRSA was transmitted over a three-month period at a hospital in northeast Thailand, the researchers are hoping their results will support evidence-based policies around infection control.

MRSA is a common cause of hospital-acquired infections, with the largest burden of infections occurring in under-resourced hospitals in the developing world. Whereas genome sequencing has previously been applied in well-resourced clinical settings to track the spread of MRSA, how transmission occurs in resource-limited settings is unknown. In a new study published today (9 December) in the journal Genome Research, researchers used genome sequencing to understand the spread of MRSA in a hospital with high transmission rates.

"In under-resourced hospitals and clinics, formal screening procedures for MRSA are not in place," said Professor Sharon Peacock of the University of Cambridge and the Wellcome Trust Sanger Institute, who led the research. "Filling gaps in our understanding of how MRSA spreads in such settings is important, since this not only highlights the problem but also provides direction to interventions that tackle this and other hospital-based pathogens."

The team of researchers from the UK, Thailand and Australia monitored all patients on two intensive care units (ICUs) at a hospital in northeast Thailand over a three-month period in order to track how and when MRSA was transmitted. During this time, five staff members and 46 patients tested positive at least once, which represented 16% of adult and 34% of paediatric patients.

Conventional bacterial genotyping approaches do not provide enough discrimination between closely-related MRSA strains to be able to pinpoint transmission from one person to another, but whole genome sequencing addresses this problem. A total of 76 MRSA populations, or isolates, were sequenced, including up to two repeat isolates from patients who tested positive for MRSA in the first screen. None of the patients or staff members who tested positive for MRSA were asymptomatic carriers.

By conventional typing, all of the MRSA identified belonged to sequence type 239, the dominant MRSA lineage worldwide. But, based on sequence data, there was considerable genetic diversity - including the presence or absence of clinically important genes such as those coding for antiseptic resistance and antibiotic resistance.

"A striking result from sequence data was the presence of multiple distinct clades, which suggests that several different variants of MRSA were circulating through the hospital at the same time," said Peacock. "We also confirmed numerous transmission events between patients after admission to the ICU, and identified a 'super-spreader' in each unit."

Read more from the original source:
Using genome sequencing to track MRSA in under-resourced hospitals

Posted in Genome | Comments Off on Using genome sequencing to track MRSA in under-resourced hospitals

Genome sequencing traces MRSA spread in high transmission setting

Posted: at 2:43 pm

Methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of hospital-acquired infections, with the largest burden of infections occurring in under-resourced hospitals. While genome sequencing has previously been applied in well-resourced clinical settings to track the spread of MRSA, transmission dynamics in settings with more limited infection control is unknown. In a study published online today in Genome Research, researchers used genome sequencing to understand the spread of MRSA in a resource-limited hospital with high transmission rates.

Patients from two intensive care units (ICUs) in a hospital in northeast Thailand were tested over a three-month period for MRSA. During this time, 46 patients and 5 staff members tested positive at least once (16% adult and 34% pediatric patients). The genetic similarity of the MRSA isolates precluded the use of conventional low-resolution genotyping approaches for distinguishing transmission from one person to another. Therefore, whole genome sequencing was performed on a total of 76 patient isolates, including up to two repeat isolates from patients who tested positive for MRSA in the first screen. None of the patients or staff members that tested positive for MRSA had symptoms of an infection but rather were carriers.

"A striking feature of the phylogenetic tree based on S. aureus whole genome sequencing was the presence of multiple distinct clades," said senior author Sharon Peacock from the University of Cambridge and Wellcome Trust Sanger Institute. "This suggested that multiple clades of the same lineage were circulating in the hospital at the same time."

Examining single base changes in the genomes of MRSA isolates allowed researchers to infer the most likely transmission routes between infected patients. Transmission events were observed between patients within the ICU, and also between patients and staff members. These results are in contrast to a previous study performed in the UK where patient-to-patient MRSA transmission in the ICU was rare.

"Our long term goal is to use such information to inform infection control practice," said Peacock. "The degree of transmission we demonstrated in our study has directly led to the prioritization of improved hand hygiene practices at the study hospital."

Genome sequencing also revealed that MRSA clades were dynamic in the ICU over the three-month period, with some clades more prevalent early in the study and others later.

Deep sequencing of isolates taken from a single patient carrying MRSA for the longest period revealed that although all isolates were of the same clade, there were small genetic differences between them, suggesting bacterial diversity within a single carrier. This lends further support to previous work suggesting that understanding transmission networks will require measures of within-host bacterial diversity as well as traditional 'shoe-leather epidemiological' data.

Story Source:

The above story is based on materials provided by Cold Spring Harbor Laboratory. Note: Materials may be edited for content and length.

Read more:
Genome sequencing traces MRSA spread in high transmission setting

Posted in Genome | Comments Off on Genome sequencing traces MRSA spread in high transmission setting

Nutrient availability can cause whole-genome recoding

Posted: at 2:43 pm

PUBLIC RELEASE DATE:

9-Dec-2014

Contact: Kevin Jiang kevin.jiang@uchospitals.edu 773-795-5227 University of Chicago Medical Center @UChicagoMed

The availability of a trace nutrient can cause genome-wide changes to how organisms encode proteins, report scientists from the University of Chicago in PLoS Biology on Dec. 9. The use of the nutrient - which is produced by bacteria and absorbed in the gut - appears to boost the speed and accuracy of protein production in specific ways.

"This is in some sense a 'you are what you eat' hypothesis,"' said senior study author D. Allan Drummond, PhD, assistant professor of biochemistry and molecular biology at the University of Chicago. "This nutrient that is absorbed through the gut looks like it can cause the recoding of an entire genome over evolutionary time."

All known organisms store the blueprint of life in their DNA, and use the information to produce proteins - the structural components and molecular engines for almost every function in a cell. To accomplish this, copies of relevant DNA regions must first be made. These copies are strings of chemical letters that serve as instructions, and are read three letters at a time by molecules known as transfer RNA (tRNA). Each tRNA has a preference for a specific three letter combination, or codon, and is attached to a single amino acid. As the instructions are read, tRNAs sequentially bind to their corresponding codon and deposit their amino acid, creating a protein.

tRNAs possess a special property known as "wobble" - a flexibility in one of the binding positions - that allows them to pair with multiple codons. This means that different spellings of genetic code can be used to create the exact same protein, similar to how sentences can be written using different synonyms. However, this flexibility comes with a cost. Some codons are less reliably read and can introduce more mistakes. As such, certain codons are thought to be favored by natural selection.

To investigate the mechanisms that underlie this process and the evolutionary consequences, Drummond, together with Tao Pan, PhD, professor of biochemistry and molecular biology, and colleagues from Cornell University, analyzed and compared thousands of genes in a dozen different species of fruit fly. They looked for the frequency at which certain codons were used to encode proteins, and how this affected the accuracy and speed of protein production.

To their surprise, they found that the availability of queuine - a trace nutrient produced by bacteria that is only available when absorbed through the gut - played a major role in determining which codons were optimal. Flies which had abundant queuine possessed a higher proportion of tRNAs with a specific modification: a portion of their wobble-binding sites was replaced with a queuine-derived molecule known as queuosine (Q).

The team found that these Q-tRNAs were able to read and process certain codons much faster and more accurately than unmodified tRNAs, and caused changes throughout the flies' genomes. Species with access to plentiful queuine favored codon spellings that were optimized for Q-tRNAs. Species with access to less queuine favored other codon spellings.

Read the original:
Nutrient availability can cause whole-genome recoding

Posted in Genome | Comments Off on Nutrient availability can cause whole-genome recoding

eczema on face – Video

Posted: at 2:42 pm


eczema on face
For this guide click this link http://bit.ly/12Gug98 What the heck is Beat Eczema? More importantly will it Help me really cure eczema? Beat Eczema by Susan Clark is now said to be the...

By: beat eczema

Read more here:
eczema on face - Video

Posted in Eczema | Comments Off on eczema on face – Video

eczema, strappo muscolare… i denti! – Video

Posted: at 2:42 pm


eczema, strappo muscolare... i denti!
A volte si hanno nell #39;osso delle memorie tossiche, per cui il dentista deve curettare l #39;osso, in questo caso per far sparire lo strappo muscolare. E l #39;altro problema? - Era un eczema, durava...

By: mercuriocarretta

See the original post here:
eczema, strappo muscolare... i denti! - Video

Posted in Eczema | Comments Off on eczema, strappo muscolare… i denti! – Video

Support for psoriasis community in new website

Posted: at 2:42 pm

At mypsoriasis.co.nz youll find suggestions for everything from how to handle kids awkward questions to dealing with an over-protective family.

Often, the stress of keeping feelings bottled up can make psoriasis symptoms worse, so the more help you can get the better youll be able to manage it. Remember, youre not alone. Theres a whole psoriasis community there to support you.

The information youll find at mypsoriasis.co.nz recognises symptoms can affect many decisions and aspects of your life and that it can take an emotional toll because of its long-term and visual nature. Youll be able to download the booklet Refusing to hide the insiders guide to psoriasis which is full of useful information to help you better understand and manage your psoriasis.

Youll also find loads of expert information from dermatologists, nurses and psychologists, along with personal stories of people just like you who share their experience of and strategies for living with the psoriasis.

As you probably already know, psoriasis is an autoimmune disease. The bodys immune system is mistakenly reacting to some of your own bodys cells, resulting in accelerated skin cell growth.

Normal skin cells replace themselves every 28 to 30 days, but skin cells affected by psoriasis mature in just 3 to 4 days and pile up instead of falling away on their own. The resulting build-up forms the silvery, scaly, red patches called plaque psoriasis.

While genetics play a role in psoriasis, scientists believe exposure to environmental triggers may propel the disease into action. For example, you may experience a worsening of your symptoms in the winter and improvement in the summer. Other triggers may include injury, stress, certain medicines and some types of infections.

Your best tool is information, plenty of which can be found at mypsoriasis.co.nz.

For example, did you know psoriasis affects more than just skin? Around 30 percent of people with psoriasis develop psoriatic arthritis that can also affect the joints, causing them to become stiff, painful and swollen. More information about psoriasis can be found mypsoriasis.co.nz.

As for how to handle those curious kids questions? How about: I have extra-happy skin. My skin cells are so happy they jump off after only a few days! Brilliant!

Go here to read the rest:
Support for psoriasis community in new website

Posted in Psoriasis | Comments Off on Support for psoriasis community in new website

Gene therapy makes a slow comeback

Posted: at 2:42 pm

Ethical questions are crucial, but they shouldnt stall the progress of this promising branch of medicine

In late November, Reuters reported a milestone in medical history: a gene therapy drug could go on sale in Germany next year, after winning the approval of European regulators two years ago. The drug, Glybera, by a Dutch firm called UniQure currently being scrutinised by Germanys federal joint committee would be the first commercial use of gene therapy in the Western world (China has had a gene therapy drug for a specific form of cancer in the market since 2004). This marks a potential turning point in an area of medicine that has been the subject of highs and lows over more than two decades of clinical trials.

Gene therapy which can involve a number of things, including replacing a malfunctioning gene or introducing a new gene with the ability to fight a disease has been in conceptual development for far longer. Its origins could be said to go back as early as the 1920s, well before the discovery of the structure of DNA, when a British scientist, Frederick Griffith, put forward what he described as the transforming principle; he successfully converted a non-virulent strain of bacteria into a virulent one, after injecting mice with both.

From the late 1960s, when the concept of gene therapy began to involve, it took several decades for the first clinical trial to take place in 1990. A young girl in the US with a genetic defect that had left her with a severely weakened immune system was successfully injected with her own white blood cells containing a corrected form of the malfunctioning gene.

However, the boost gene therapy got following that first successful trial was soon tarnished, in the view of the public, by a tragedy in 1999; an 18-year-old American boy, who had a mild version of a liver condition, which meant his body couldnt process ammonia, died during a gene therapy treatment. This was after a massive response by his immune system to the vector or carrier used to introduce the corrected gene.

The episode raised a number of issues including that of informed consent of those participating in clinical trials as well as the fact that identifying and correcting a defective gene was far from the only challenge facing gene therapy. Selecting the appropriate vector was also vital and not without risks.

Despite predictions that gene therapy would be lastingly damaged by the tragedy, research and trials continued with many promising results for a range of conditions ranging from immune system conditions to cancer, cystic fibrosis, Parkinsons disease and hemophilia.

The renewed confidence in gene therapy is highlighted by the fact that the worlds largest pharmaceutical companies have also entered the market (earlier this week, Pfizer announced collaboration with Spark Therapeutics, a Philadelphia based company on the development of a hemophilia B treatment).

Over 1,700 approved gene therapy trials have taken place in the past two decades, estimated an article on the history of gene therapy in Gene magazine last year with many successes and a few hits. Among the latter were trials conducted in France in 2001 on Severe Combined Immunodeficiency, a condition where the immune system is so crippled that in one case it required a boy to live in a germ-free bubble. Several infants involved in the trial subsequently developed leukemia, though other clinical trials for gene therapy since have been successful.

There have been some understandable public concerns about gene therapy and its impact on the one hand it offers that tantalising potential of curing some of the most lethal conditions while on the other, tampering with genetic makeup is something that has long conjured up fears in the public imagination of genetic engineering and exacerbating discrimination against those with disabilities and disease.

See more here:
Gene therapy makes a slow comeback

Posted in Gene Medicine | Comments Off on Gene therapy makes a slow comeback

Page 2,877«..1020..2,8762,8772,8782,879..2,8902,900..»